Evolus, Inc. (LON: 0K16)
London flag London · Delayed Price · Currency is GBP · Price in USD
14.18
+0.51 (3.72%)
Jan 22, 2025, 6:49 PM BST

Evolus Statistics

Total Valuation

Evolus has a market cap or net worth of GBP 726.48 million. The enterprise value is 762.89 million.

Market Cap 726.48M
Enterprise Value 762.89M

Important Dates

The next estimated earnings date is Monday, March 10, 2025.

Earnings Date Mar 10, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +6.72%
Shares Change (QoQ) +0.68%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 50.25M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -18.44
EV / Sales 3.78
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -44.00

Financial Position

The company has a current ratio of 2.47, with a Debt / Equity ratio of 22.05.

Current Ratio 2.47
Quick Ratio 2.13
Debt / Equity 22.05
Debt / EBITDA n/a
Debt / FCF -5.59
Interest Coverage -1.73

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -9.93%
Return on Capital (ROIC) -18.11%
Revenue Per Employee 575,391
Profits Per Employee -128,505
Employee Count 273
Asset Turnover 1.25
Inventory Turnover 4.59

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +19.05% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +19.05%
50-Day Moving Average 12.58
200-Day Moving Average 13.51
Relative Strength Index (RSI) 67.50
Average Volume (20 Days) 4,009

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 8.01

Income Statement

In the last 12 months, Evolus had revenue of GBP 185.28 million and -41.38 million in losses. Loss per share was -0.68.

Revenue 185.28M
Gross Profit 129.59M
Operating Income -23.55M
Pretax Income -41.13M
Net Income -41.38M
EBITDA -19.60M
EBIT -23.55M
Loss Per Share -0.68
Full Income Statement

Balance Sheet

The company has 63.44 million in cash and 96.90 million in debt, giving a net cash position of -33.46 million.

Cash & Cash Equivalents 63.44M
Total Debt 96.90M
Net Cash -33.46M
Net Cash Per Share n/a
Equity (Book Value) 4.39M
Book Value Per Share 0.07
Working Capital 66.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.41 million and capital expenditures -927,402, giving a free cash flow of -17.34 million.

Operating Cash Flow -16.41M
Capital Expenditures -927,402
Free Cash Flow -17.34M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 69.94%, with operating and profit margins of -12.71% and -22.33%.

Gross Margin 69.94%
Operating Margin -12.71%
Pretax Margin -22.20%
Profit Margin -22.33%
EBITDA Margin -10.58%
EBIT Margin -12.71%
FCF Margin n/a

Dividends & Yields

Evolus does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.72%
Shareholder Yield -6.72%
Earnings Yield -5.70%
FCF Yield -2.39%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Evolus has an Altman Z-Score of -0.62. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.62
Piotroski F-Score n/a